Home »
1996 Issues »
61 FR (09/20/1996) » 96-24213. Notice Pursuant to the National Cooperative Research and Production Act of 1993the Ohio Aerospace Institute Computer Assisted Minimally Invasive Surgery Project
96-24213. Notice Pursuant to the National Cooperative Research and Production Act of 1993the Ohio Aerospace Institute Computer Assisted Minimally Invasive Surgery Project
[Federal Register Volume 61, Number 184 (Friday, September 20, 1996)]
[Notices]
[Page 49484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-24213]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--the Ohio Aerospace Institute Computer Assisted
Minimally Invasive Surgery Project
Notice is hereby given that, on September 4, 1996, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), the Ohio Aerospace
Institute Computer Assisted Minimally Invasive Surgery Project
(``CAMIS'') has filed written notification simultaneously with the
Attorney General and the Federal Trade Commission disclosing (1) the
identities of the parties and (2) the nature and objectives of the
venture. The notifications were filed for the purpose of invoking the
Act's provisions limiting the recovery of plaintiffs to actual damages
under specified circumstances. Pursuant to Section 6(b) of the Act, the
identities of the parties are Ohio Aerospace Institute, Brook Park, OH;
Cleveland Clinic Foundation, Cleveland, OH; Picker International,
Highland Heights, OH; Wright State University, Dayton, OH; and
Washington University, St. Louis, MO. The project's general area of
planned activity is a non-profit joint venture dedicated to research
and developing ``vision technologies'' that can aid doctors in various
surgical procedures. CAMIS will provide for the enhancement of existing
CAMIS prototype systems with aerospace avionics technologies, and its
clinical trials will concentrate on the early treatment of several
forms of cancer (brain tumors, prostate and breast) to demonstrate the
significant improvements to patient care and cost that this technology
provides.
Membership in this project remains open, and CAMIS intends to file
additional written notification disclosing all changes in membership.
Information regarding participation in CAMIS may be obtained from
Eileen Pickett, Ohio Aerospace Institute, Cleveland, OH.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 96-24213 Filed 9-19-96; 8:45 am]
BILLING CODE 4410-01-M
Document Information
- Published:
- 09/20/1996
- Department:
- Antitrust Division
- Entry Type:
- Notice
- Document Number:
- 96-24213
- Pages:
- 49484-49484 (1 pages)
- PDF File:
-
96-24213.pdf